PCNA
MOLECULAR TARGETproliferating cell nuclear antigen
PCNA (proliferating cell nuclear antigen) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PCNA
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | liothyronine | 4.23 | 68 |
| 2 | molibresib | 3.81 | 44 |
| 3 | tiratricol | 3.04 | 20 |
| 4 | thyropropic acid | 1.79 | 5 |
| 5 | Oleanolic Acid | 1.10 | 2 |
| 6 | Triiodothyronine | 0.69 | 1 |
About PCNA as a Drug Target
PCNA (proliferating cell nuclear antigen) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented PCNA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PCNA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.